These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33059564)

  • 21. An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations.
    Prajapati SK; Malaiya A; Mishra G; Jain D; Kesharwani P; Mody N; Ahmadi A; Paliwal R; Jain A
    J Ethnopharmacol; 2022 Oct; 296():115420. PubMed ID: 35654349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.
    Mirtaleb MS; Mirtaleb AH; Nosrati H; Heshmatnia J; Falak R; Zolfaghari Emameh R
    Biomed Pharmacother; 2021 Jun; 138():111518. PubMed ID: 33774315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts.
    Strub DJ; Talma M; Strub M; Rut W; Zmudzinski M; Brud W; Neyts J; Vangeel L; Zhang L; Sun X; Lv Z; Nayak D; Olsen SK; Hilgenfeld R; Jochmans D; Drąg M
    Sci Rep; 2022 Aug; 12(1):14230. PubMed ID: 35987981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current pharmacological treatments for SARS-COV-2: A narrative review.
    Nittari G; Pallotta G; Amenta F; Tayebati SK
    Eur J Pharmacol; 2020 Sep; 882():173328. PubMed ID: 32603692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.
    Chakraborty C; Sharma AR; Sharma G; Bhattacharya M; Lee SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):4016-4026. PubMed ID: 32329877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2.
    Malik P; Jain S; Jain P; Kumawat J; Dwivedi J; Kishore D
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100382. PubMed ID: 35040187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
    Shahzad F; Anderson D; Najafzadeh M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2
    Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets.
    Romeo I; Mesiti F; Lupia A; Alcaro S
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
    Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
    Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral Efficacy of Molnupiravir for COVID-19 Treatment.
    Bai Y; Shen M; Zhang L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules.
    Prasad A; Muthamilarasan M; Prasad M
    Plant Cell Rep; 2020 Sep; 39(9):1109-1114. PubMed ID: 32561979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus management and control: Nutrition and alternative medicines.
    Guha S; Chakraborty A
    Nutr Health; 2022 Dec; 28(4):635-645. PubMed ID: 33858237
    [No Abstract]   [Full Text] [Related]  

  • 40. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
    Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
    Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.